Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Seminars in Hematology|July 15, 2005
Pharmacology of 5-Aza-2'-deoxycytidine (decitabine)Richard L MomparlerPharmaceuticals (Basel, Switzerland)|November 28, 2013
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)Richard L MomparlerExperimental Hematology & Oncology|August 8, 2013
Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemiaRichard L MomparlerSeminars in Oncology|October 8, 2005
Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine)Richard L MomparlerFrontiers in Oncology|August 3, 2013
Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine)Richard L MomparlerAnti-Cancer Drugs|April 13, 2004
Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell linesAnnie Hurtubise, Richard L MomparlerCancer Chemotherapy and Pharmacology|June 20, 2006
Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cellsAnnie Hurtubise, Richard L MomparlerExpert Opinion on Investigational Drugs|May 26, 2015
Targeting of cancer stem cells by inhibitors of DNA and histone methylationRichard L Momparler, Sylvie CôtéClinical Epigenetics|February 2, 2013
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapyMetin Karahoca, Richard L MomparlerPageof 4